Unique ID issued by UMIN | UMIN000041645 |
---|---|
Receipt number | R000047534 |
Scientific Title | Relationship between Maternal Blood Protein Concentration and Reactive Oxygen and Vascular Endothelial Function in Hypertensive disorders of pregnancy(HDP) Pregnant Women |
Date of disclosure of the study information | 2020/09/02 |
Last modified on | 2020/09/02 10:32:51 |
Relationship between Maternal Blood Protein Concentration and Reactive Oxygen and Vascular Endothelial Function in Hypertensive disorders of pregnancy (HDP) Pregnant Women
Relationship between Maternal Blood Protein Concentration and Reactive Oxygen and Vascular Endothelial Function in Hypertensive disorders of pregnancy(HDP) Pregnant Women
Relationship between Maternal Blood Protein Concentration and Reactive Oxygen and Vascular Endothelial Function in Hypertensive disorders of pregnancy(HDP) Pregnant Women
Relationship between Maternal Blood Protein Concentration and Reactive Oxygen and Vascular Endothelial Function in Hypertensive disorders of pregnancy(HDP) Pregnant Women
Japan |
Pregnant women with
Preeclampsia
Gestatonal hypertension
Obstetrics and Gynecology |
Others
NO
This study aimed to assess the serum levels of free radical, as well as albumin and those impact on the flow-mediated dilation (FMD) reflecting vascular endothelial function in patients with preeclampsia (PE) and gestational hypertension (GH).
Bio-equivalence
The serum levels of free radical, as well as albumin and those impact on the flow-mediated dilation (FMD) reflecting vascular endothelial function in patients with preeclampsia (PE) and gestational hypertension (GH).
Observational
20 | years-old | <= |
34 | years-old | >= |
Female
PE was defined systolic blood pressure (BP) >=140 mmHg or diastolic BP>=90 mmHg after 20 weeks gestation, proteinuria (>=300 mg protein/24 hours), other maternal organ dysfunction, and uteroplacental dysfunction. GH was defined systolic BP >=140 mmHg or diastolic BP>=90 mmHg after 20 weeks gestation.
The participants smoked, consumed alcohol or caffeine, or had a history of thyroid disease, hypertension, diabetes mellitus, hyperlipidemia, or liver disease and were not taking any medications known to influence lipoprotein metabolism.
90
1st name | Saitou |
Middle name | |
Last name | Takuya |
Aichi Medical University School of
Medicine
Department of Obstetrics and Gynecology
480-1195
Nagakute-city, Aichi 480-1195, Japan
0561-62-3311
saito1023@aichi-med-u.ac.jp
1st name | Saitou |
Middle name | |
Last name | Takuya |
Aichi Medical University
Department of Obstetrics and Gynecology
480-1195
Nagakute-city, Aichi 480-1195, Japan
0561-62-3311
saito1023@aichi-med-u.ac.jp
Aichi Medical University School of
Medicine
Aichi Medical University School of
Medicine
Self funding
Aichi Medical University School of
Nagakute-city, Aichi 480-1195, Japan
0561-62-3311
aichi-med@esct.bvits.com
NO
2020 | Year | 09 | Month | 02 | Day |
Unpublished
75
Open public recruiting
2018 | Year | 11 | Month | 26 | Day |
2018 | Year | 11 | Month | 26 | Day |
2018 | Year | 11 | Month | 26 | Day |
2024 | Year | 03 | Month | 31 | Day |
No special notes
2020 | Year | 09 | Month | 02 | Day |
2020 | Year | 09 | Month | 02 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000047534
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |